Brent Clark
Foot & Ankle Surgery · St George, UTNPI 1407820418
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 50.0% of the total. Reporting peaked in 2021 at $1,989 and has fallen 92.4% since, to $152 in 2025.
Across 67 payments — averaging $79.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$3K
- Summit Surgical Corp.$1K
- Stryker$315
- Amgen$248
- Rikco International, LLC$211
- Nevro Corp.$161
- plus $475 from 10 others
What the payments were for
- Speaking & faculty fees$120%
- Travel & lodging$1,49628%
- Food & beverage$2,32344%
- Education$1,41126%
- Gifts$962%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 26 | $2,668 |
| Summit Surgical Corp. | 3 | $1,259 |
| Stryker(2 entities) | 8 | $315 |
| Amgen(2 entities) | 6 | $248 |
| Rikco International, LLC | 5 | $211 |
| Nevro Corp. | 2 | $161 |
| Axogen | 1 | $116 |
| Smith+Nephew | 3 | $90 |
| Kerecis Limited | 3 | $89 |
| Merck | 3 | $40 |
| Bioventus LLC | 2 | $38 |
| Orthofix Medical, Inc. | 1 | $32 |
| Heron Therapeutics, Inc. | 1 | $20 |
| Osiris Therapeutics Inc. | 1 | $18 |
| AbbVie | 1 | $17 |
| Medtronic | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$2,302
- Omnia$145
- KRYSTEXXA$125
- AxoGuard Nerve Connector$116
- AxoGuard Nerve Protector$116
How this compares
$5,338 in reported general payments places this provider in the 60th percentile of 104 foot & ankle surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluconazole | 137 | $1,620 |
| Ketoconazole | 49 | $1,214 |
| Terbinafine Hcl | 141 | $692 |
| Celecoxib | 11 | $356 |
| Gabapentin | 28 | $298 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $241 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 31 | $217 |
| Doxycycline Hyclate | 24 | $211 |
| Cephalexin | 15 | $191 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in St George
- Carl van GilsSt George$23K
- Ryan PetersonSt George$5K
- Gregory AndersonSalt Lake City$1.6M
- Ryan RigbyLogan$975K
- Florian NickischSalt Lake City$474K
- Brian LiljenquistSalt Lake City$263K
- Douglas TooleSalt Lake City$258K
- Francis ClarkWest Jordan$125K
- David SeegmillerSalt Lake City$120K
- Scott ClarkWest Jordan$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.